{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:53:39Z","timestamp":1790178819758,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.tem.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T04:20:56Z","timestamp":1361852456000},"page":"351-360","source":"Crossref","is-referenced-by-count":111,"title":["Islet inflammation: a unifying target for diabetes treatment?"],"prefix":"10.1016","volume":"24","author":[{"given":"Yumi","family":"Imai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca D.","family":"Dobrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry L.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2013.01.007_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/187153011794982086","article-title":"The evil axis of obesity, inflammation and type-2 diabetes","volume":"11","author":"Das","year":"2011","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.tem.2013.01.007_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaut.2011.02.004","article-title":"Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children","volume":"37","author":"Ziegler","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.tem.2013.01.007_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1464-5491.2010.03160.x","article-title":"Association between childhood obesity and subsequent type 1 diabetes: a systematic review and meta-analysis","volume":"28","author":"Verbeeten","year":"2011","journal-title":"Diabet. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0020","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0030","doi-asserted-by":"crossref","first-page":"T37","DOI":"10.1530\/JOE-12-0278","article-title":"The role of adipokines in beta-cell failure of type 2 diabetes","volume":"216","author":"Dunmore","year":"2013","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2013.01.007_bib0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/dmrr.1279","article-title":"\u2018Sensing\u2019 the link between type 1 and type 2 diabetes","volume":"27","author":"Tsui","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.tem.2013.01.007_bib0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ceca.2010.07.007","article-title":"Evidence that low-grade systemic inflammation can induce islet dysfunction as measured by impaired calcium handling","volume":"48","author":"Dula","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.tem.2013.01.007_bib0045","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tem.2013.01.007_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2012","article-title":"Hypoxia and adipose tissue function and dysfunction in obesity","volume":"93","author":"Trayhurn","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2013.01.007_bib0055","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI45887","article-title":"Adipose tissue remodeling and obesity","volume":"121","author":"Sun","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.01.007_bib0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc12-0421","article-title":"\u03b2-Cell mass and turnover in humans: effects of obesity and aging","volume":"36","author":"Saisho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2013.01.007_bib0065","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1749-6632.2011.06388.x","article-title":"Hypothalamic inflammation: a double-edged sword to nutritional diseases","volume":"1243","author":"Cai","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2013.01.007_bib0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00125-010-1972-9","article-title":"TNF-alpha acutely upregulates amylin expression in murine pancreatic beta cells","volume":"54","author":"Cai","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0075","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2337\/db10-1707","article-title":"Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome","volume":"60","author":"Lamers","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0080","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00463.2010","article-title":"Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice","volume":"300","author":"Dobrian","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.tem.2013.01.007_bib0085","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0168-8227(11)70012-2","article-title":"Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy?","volume":"93","author":"van Raalte","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.tem.2013.01.007_bib0090","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00125-010-1707-y","article-title":"Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes","volume":"53","author":"Igoillo-Esteve","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2012.01.023","article-title":"Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation","volume":"15","author":"Eguchi","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2009.03.011","article-title":"As a matter of fat","volume":"10","author":"Brookheart","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-1-60761-720-4_17","article-title":"Oxidative stress and beta cell dysfunction","volume":"900","author":"Lightfoot","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tem.2013.01.007_bib0110","doi-asserted-by":"crossref","first-page":"e11499","DOI":"10.1371\/journal.pone.0011499","article-title":"Gene expression profiles of \u03b2-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes","volume":"5","author":"Marselli","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2013.01.007_bib0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1742-1241.2008.01789.x","article-title":"Modulating an oxidative\u2013inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function","volume":"62","author":"Lamb","year":"2008","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.tem.2013.01.007_bib0120","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cmet.2012.09.001","article-title":"Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic beta cell fate in response to cytokines","volume":"16","author":"Hansen","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mce.2012.03.004","article-title":"Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction","volume":"358","author":"Weaver","year":"2012","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2013.01.007_bib0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molmed.2012.06.010","article-title":"ER stress-induced inflammation: does it aid or impede disease progression?","volume":"18","author":"Garg","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00125-012-2762-3","article-title":"Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation","volume":"56","author":"Eizirik","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cmet.2012.07.005","article-title":"Thioredoxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome","volume":"16","author":"Oslowski","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cmet.2012.07.007","article-title":"IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress","volume":"16","author":"Lerner","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0150","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/db07-0715","article-title":"Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis","volume":"57","author":"Chen","year":"2008","journal-title":"Diabetes"},{"issue":"Suppl. 3","key":"10.1016\/j.tem.2013.01.007_bib0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1463-1326.2012.01657.x","article-title":"Metabolic stress, IAPP and islet amyloid","volume":"14","author":"Montane","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0160","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00125-011-2338-7","article-title":"cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets","volume":"55","author":"Subramanian","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0165","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tem.2013.01.007_bib0175","doi-asserted-by":"crossref","first-page":"e36200","DOI":"10.1371\/journal.pone.0036200","article-title":"Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-like receptor-4 and NF-kappaB signalling","volume":"7","author":"Amyot","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2013.01.007_bib0180","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1007\/s00125-012-2672-4","article-title":"Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease","volume":"55","author":"Atkinson","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0185","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1210\/en.2011-2090","article-title":"Mild endoplasmic reticulum stress augments the proinflammatory effect of IL-1beta in pancreatic rat beta-cells via the IRE1alpha\/XBP1s pathway","volume":"153","author":"Miani","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2013.01.007_bib0190","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/eji.201141476","article-title":"Reducing or increasing \u03b2-cell apoptosis without inflammation does not affect diabetes initiation in neonatal NOD mice","volume":"41","author":"Carrington","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0195","doi-asserted-by":"crossref","first-page":"39632","DOI":"10.1074\/jbc.M111.253591","article-title":"Cytokines tumor necrosis factor-alpha and interferon-gamma induce pancreatic beta-cell apoptosis through STAT1-mediated Bim protein activation","volume":"286","author":"Barthson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2013.01.007_bib0200","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-008-1085-x","article-title":"Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis","volume":"51","author":"Irving-Rodgers","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0205","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1172\/JCI46177","article-title":"Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes","volume":"122","author":"Ziolkowski","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.01.007_bib0210","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.1001388","article-title":"Inhibition of autoimmune diabetes by TLR2 tolerance","volume":"187","author":"Kim","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cyto.2011.03.023","article-title":"Knockout of Toll-like receptor-4 attenuates the pro-inflammatory state of diabetes","volume":"55","author":"Devaraj","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.tem.2013.01.007_bib0220","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.4049\/jimmunol.0901814","article-title":"TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes","volume":"184","author":"Zhang","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0225","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2337\/db12-0099","article-title":"Dysregulated Toll-like receptor-induced interleukin-1beta and interleukin-6 responses in subjects at risk for the development of type 1 diabetes","volume":"61","author":"Alkanani","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0230","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2337\/db11-0853","article-title":"Expression and regulation of chemokines in murine and human type 1 diabetes","volume":"61","author":"Sarkar","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4049\/jimmunol.1101215","article-title":"IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes","volume":"188","author":"Joseph","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0240","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4049\/jimmunol.1000180","article-title":"Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model","volume":"187","author":"Van Belle","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0245","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.4049\/jimmunol.1103111","article-title":"Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model","volume":"189","author":"Saxena","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0250","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00125-012-2732-9","article-title":"Production and function of IL-12 in islets and beta cells","volume":"56","author":"Taylor-Fishwick","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2009.01.003","article-title":"CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling","volume":"9","author":"Schulthess","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.plipres.2010.10.005","article-title":"Functional and pathological roles of the 12- and 15-lipoxygenases","volume":"50","author":"Dobrian","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.tem.2013.01.007_bib0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2009-1102","article-title":"12-Lipoxygenase products reduce insulin secretion and \u03b2-cell viability in human islets","volume":"95","author":"Ma","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0270","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tem.2009.12.010","article-title":"Cytokine production by islets in health and diabetes: cellular origin, regulation and function","volume":"21","author":"Donath","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0280","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/db08-0178","article-title":"Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells","volume":"58","author":"Grunnet","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0285","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cmet.2012.10.009","article-title":"Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes","volume":"16","author":"Mahdi","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0290","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/db09-0881","article-title":"Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells","volume":"59","author":"Roggli","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0295","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1172\/JCI38924","article-title":"The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice","volume":"120","author":"Maier","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.01.007_bib0300","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2337\/db08-0625","article-title":"Increased expression of CCL2 in insulin-producing cells of transgenic mice promotes mobilization of myeloid cells from the bone marrow, marked insulitis, and diabetes","volume":"57","author":"Martin","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0305","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1073\/pnas.1115308109","article-title":"Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells","volume":"109","author":"Kriegel","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2013.01.007_bib0310","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2613.2010.00713.x","article-title":"Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains","volume":"91","author":"Jones","year":"2010","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.tem.2013.01.007_bib0315","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/dc10-0579","article-title":"Identification of autoantibody-negative autoimmune type 2 diabetic patients","volume":"34","author":"Brooks-Worrell","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2013.01.007_bib0320","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/db12-0562","article-title":"Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials","volume":"62","author":"Staeva","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molmed.2012.01.001","article-title":"New and future immunomodulatory therapy in type 1 diabetes","volume":"18","author":"Tooley","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0330","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaci.2011.08.008","article-title":"Effect of rituximab on human in vivo antibody immune responses","volume":"128","author":"Pescovitz","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0335","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1399-5448.2011.00761.x","article-title":"Preliminary studies related to anti-interleukin-1beta therapy in children with newly diagnosed type 1 diabetes","volume":"12","author":"Sumpter","year":"2011","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0340","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/db11-1033","article-title":"Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation","volume":"61","author":"Ablamunits","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0345","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.4049\/jimmunol.1200467","article-title":"Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes","volume":"188","author":"Czyzyk","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0350","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0355","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1215327","article-title":"The ancient drug salicylate directly activates AMP-activated protein kinase","volume":"336","author":"Hawley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.tem.2013.01.007_bib0360","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4236\/jdm.2012.22040","article-title":"Amelioration of type 1 diabetes following treatment of non-obese diabetic mice with INGAP and lisofylline","volume":"2","author":"Tersey","year":"2012","journal-title":"J. Diabetes Mellitus"},{"key":"10.1016\/j.tem.2013.01.007_bib0365","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.abb.2012.09.014","article-title":"Transcriptional and translational regulation of cytokine signaling in inflammatory beta-cell dysfunction and apoptosis","volume":"528","author":"Novotny","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tem.2013.01.007_bib0370","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2119\/molmed.2011.00021","article-title":"Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus","volume":"17","author":"Christensen","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0375","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1007\/s00125-012-2615-0","article-title":"Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children","volume":"55","author":"Lundh","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0380","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2337\/db07-1795","article-title":"Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway","volume":"58","author":"Lee","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0385","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1007\/s00125-011-2288-0","article-title":"Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function","volume":"54","author":"Caton","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.tem.2013.01.007_bib0390","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/db10-0901","article-title":"High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition","volume":"60","author":"Bellenger","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0395","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/me.2011-1181","article-title":"PPAR-gamma activation restores pancreatic islet SERCA2 levels and prevents beta-cell dysfunction under conditions of hyperglycemic and cytokine stress","volume":"26","author":"Kono","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2013.01.007_bib0400","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11906-008-0025-y","article-title":"Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease","volume":"10","author":"Patel","year":"2008","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.tem.2013.01.007_bib0405","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1172\/JCI30910","article-title":"Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice","volume":"117","author":"Morioka","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.01.007_bib0410","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.2337\/db09-1805","article-title":"Deletion of Pten in pancreatic \u03b2-cells protects against deficient \u03b2-cell mass and function in mouse models of type 2 diabetes","volume":"59","author":"Wang","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0415","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.tem.2013.01.007_bib0420","doi-asserted-by":"crossref","first-page":"33623","DOI":"10.1074\/jbc.M109.085084","article-title":"Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion","volume":"285","author":"Wijesekara","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2013.01.007_bib0425","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s11695-011-0357-6","article-title":"Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after roux-en-y gastric bypass surgery","volume":"21","author":"Chai","year":"2011","journal-title":"Obes. Surg."},{"key":"10.1016\/j.tem.2013.01.007_bib0430","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.peptides.2010.02.004","article-title":"Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin","volume":"31","author":"Brown","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.tem.2013.01.007_bib0435","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1463-1326.2012.01626.x","article-title":"Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPARgamma-dependent and PPARgamma-independent mechanisms","volume":"14","author":"Rao","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.tem.2013.01.007_bib0440","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1172\/JCI58056","article-title":"Deficit of tRNALys modification by Cdkal1 causes the development of type 2 diabetes in mice","volume":"121","author":"Wei","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2013.01.007_bib0445","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.2011.04501.x","article-title":"Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation","volume":"167","author":"Brooks-Worrell","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tem.2013.01.007_bib0450","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2337\/db11-1293","article-title":"Islet beta-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model","volume":"61","author":"Tersey","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0455","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","article-title":"IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat","volume":"106","author":"Ehses","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2013.01.007_bib0460","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/diabetes.53.1.113","article-title":"IL-1 receptor deficiency slows progression to diabetes in the NOD mouse","volume":"53","author":"Thomas","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0465","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2012.07.002","article-title":"Biomarkers and immune-modulating therapies for type 2 diabetes","volume":"33","author":"Brooks-Worrell","year":"2012","journal-title":"Trends Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.tem.2013.01.007_bib0470","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.tem.2013.01.007_bib0475","doi-asserted-by":"crossref","first-page":"e35410","DOI":"10.1371\/journal.pone.0035410","article-title":"Lack of association of type 2 diabetes susceptibility genotypes and body weight on the development of islet autoimmunity and type 1 diabetes","volume":"7","author":"Winkler","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tem.2013.01.007_bib0480","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2337\/dc11-2219","article-title":"Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes","volume":"35","author":"Cavelti-Weder","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2013.01.007_bib0485","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc11-0357","article-title":"Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial","volume":"34","author":"Ramos-Zavala","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.tem.2013.01.007_bib0490","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am. Heart J."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276013000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276013000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T12:29:14Z","timestamp":1539865754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276013000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":98,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1043276013000192"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2013.01.007","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}